e-learning
resources
Berlin 2008
Monday, 06.10.2008
Genetic risk factors for asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
C-reactive protein serum levels, genotypes and the risk of COPD. The Rotterdam study
Y. van Durme, K. Verhamme, G. Van Pottelberge, J. Witteman, A. Uitterlinden, G. Joos, A. Hofman, G. Brusselle, B. Stricker (Ghent, Belgium; Rotterdam, Netherlands)
Source:
Annual Congress 2008 - Genetic risk factors for asthma and COPD
Session:
Genetic risk factors for asthma and COPD
Session type:
Oral Presentation
Number:
2761
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. van Durme, K. Verhamme, G. Van Pottelberge, J. Witteman, A. Uitterlinden, G. Joos, A. Hofman, G. Brusselle, B. Stricker (Ghent, Belgium; Rotterdam, Netherlands). C-reactive protein serum levels, genotypes and the risk of COPD. The Rotterdam study. Eur Respir J 2008; 32: Suppl. 52, 2761
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
C-reactive protein levels and the risk of COPD in a general population: the Rotterdam study
Source: Annual Congress 2007 - Mechanisms and new treatments of COPD
Year: 2007
The study on the association of serum C-reactive protein level with the risk of lung cancer
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009
Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity.
Source: International Congress 2017 – COPD biomarkers
Year: 2017
Is there a relationship between severity of COPD and C-reactive protein (CRP) levels?
Source: Eur Respir J 2006; 28: Suppl. 50, 37s
Year: 2006
The association of C-reactive protein, serum amyloid-A and fibrinogen with prevalent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 506s
Year: 2001
High-sensitive C-reactive protein is associated with reduced lung function in young adults
Source: Eur Respir J 2009; 33: 382-388
Year: 2009
LSC - 2021 - The relationship between the level of C-reactive protein and the general cardiovascular risk in patients with COPD and hypertension
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
PP302 – The relationship between the level of C-reactive protein and the general cardiovascular risk in patients with COPD and hypertension
Source: ERS Lung Science Conference 2021
Year: 2021
C-reactive protein (CRP) as a risk marker in COPD patients with ischaemic heart disease
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Individual variation in the levels of procalcitonin, neopterin, CRP and MR-proANP during a COPD exacerbation and clinical stable state
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009
Genetic determinants of C-reactive protein in COPD
Source: Eur Respir J 2006; 28: 1156-1162
Year: 2006
Serum leptin, insulin and C-reactive protein (CRP) in patients with pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 343s
Year: 2006
C-reactive protein (CRP) as a marker of disease severity in community acquired pneumonia patients with sepsis
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012
Variations in C-reactive protein gene and COPD: tagging SNPs analysis in case-control study
Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight
Year: 2007
Does the serum C-reactive protein (CRP) predict adverse outcomes in patients admitted with community acquired pneumonia?
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Prognosis value of initial C-reactive protein (CRP) assay in patients with community acquired pneumonia
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?
Source: Eur Respir J 2008; 32: 1451-1457
Year: 2008
The polymorphisms of C-reactive protein gene modify the association between central obesity, asthma and lung function in Taiwan
Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors
Year: 2011
Association between C-reactive protein levels and outcome in acute lung injury in children
Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept